Abnormalities, Drug-Induced
"Abnormalities, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Descriptor ID |
D000014
|
| MeSH Number(s) |
C16.131.042
|
| Concept/Terms |
Abnormalities, Drug-Induced- Abnormalities, Drug-Induced
- Abnormalities, Drug Induced
- Drug-Induced Abnormalities
- Abnormality, Drug-Induced
- Drug Induced Abnormalities
- Drug-Induced Abnormality
|
Below are MeSH descriptors whose meaning is more general than "Abnormalities, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Abnormalities, Drug-Induced".
This graph shows the total number of publications written about "Abnormalities, Drug-Induced" by people in this website by year, and whether "Abnormalities, Drug-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Abnormalities, Drug-Induced" by people in Profiles.
-
Stadelmaier R, Nasri H, Deutsch CK, Bauman M, Hunt A, Stodgell CJ, Adams J, Holmes LB. Exposure to Sodium Valproate during Pregnancy: Facial Features and Signs of Autism. Birth Defects Res. 2017 Aug 15; 109(14):1134-1143.
-
Hansen C, Andrade SE, Freiman H, Dublin S, Haffenreffer K, Cooper WO, Cheetham TC, Toh S, Li DK, Raebel MA, Kuntz JL, Perrin N, Rosales AG, Carter S, Pawloski PA, Maloney EM, Graham DJ, Sahin L, Scott PE, Yap J, Davis R. Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies. Pharmacoepidemiol Drug Saf. 2016 Feb; 25(2):170-8.
-
Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol. 2015 May; 125(5):1224-1235.
-
Orup HI, Deutsch CK, Holmes LB. Laser light scan analysis of the "anticonvulsant face". Birth Defects Res A Clin Mol Teratol. 2014 Dec; 100(12):905-11.
-
Fantasia HC. A new pharmacologic treatment for nausea and vomiting of pregnancy. Nurs Womens Health. 2014 Feb-Mar; 18(1):73-77.
-
Gottlieb AS. A teachable moment for providers and patients alike: contraceptive counseling when prescribing medications with teratogenic potential. J Womens Health (Larchmt). 2013 Oct; 22(10):795-6.
-
Schwarz EB, Mattocks K, Brandt C, Borrero S, Zephyrin LC, Bathulapalli H, Haskell S. Counseling of female veterans about risks of medication-induced birth defects. J Gen Intern Med. 2013 Jul; 28 Suppl 2:S598-603.
-
Byatt N, Deligiannidis KM, Freeman MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand. 2013 Feb; 127(2):94-114.
-
Lee LM, Leung CY, Tang WW, Choi HL, Leung YC, McCaffery PJ, Wang CC, Woolf AS, Shum AS. A paradoxical teratogenic mechanism for retinoic acid. Proc Natl Acad Sci U S A. 2012 Aug 21; 109(34):13668-73.
-
Maloney ME, Stone SP. Isotretinoin and iPledge: a view of results. J Am Acad Dermatol. 2011 Aug; 65(2):418-419.